Taylor Ljt
Research Subjects
Research Interests
Taylor Ljt has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Jose Alfonso Rodriguez
University of California, Los Angeles
4 shared publications Gavriella Siman-Tov
UTMB: The University of Texas Medical Branch at Galveston
1 shared publicationGustavo Helguera
Instituto de Biología y Medicina Experimental (IBYME-CONICET)
1 shared publication- Gustavo Helguera
Instituto de Biología y Medicina Experimental (IBYME-CONICET)
1 shared publication Junki Maruyama
UTMB: The University of Texas Medical Branch
1 shared publication- Junki Maruyama
Department of Pathology, University of Texas Medical Branch, Galveston, USA
1 shared publication
Latest Publications
- Open Access
- 23 June 2026
- Published by American Society for Microbiology in Journal of Virology
- Vol. 100 (6) , e0162625
Structures of New World mammarenavirus glycoproteins as targets for antibody-mediated neutralization
New World mammarenaviruses (NWMs) are viral pathogens endemic to the Americas, where several have acquired the capability for zoonotic transmission, leading to sporadic but potentially lethal viral hemorrhagic fever in humans. Several NWMs are classified as category A pathogens and are considered a persistent threat to human health due to their high case mortality rates, ability to spread through airborne transmission, and limited therapeutic and treatment options against them. Infection is mediated by the tripartite glycoprotein complex (GPC), which is the sole protein expressed on the viral envelope. The GPC, consisting of a receptor-binding domain (GP1), a fusion-enabling domain (GP2), and a stable signal peptide (SSP), governs viral entry initiated through the transferrin receptor 1 (TfR1). Subtle changes in GPC sequence and structure can drastically influence host range, immune recognition, and viral fitness, underscoring its central role in arenavirus pathogenicity and making it a prime target for therapeutic intervention. Over the past decade, advances in structural biology have enabled the elucidation of the molecular architecture of the NWM GPC and its interaction with host receptors and neutralizing antibodies. In this review, we discuss the information gleaned from structural interrogation of the NWM GPC and the significance of these findings on current therapeutic development against these lethal pathogens.
- 23 June 2026
- Published by American Society for Microbiology in Journal of Virology
- Vol. 100 (6) , e0162625
Open AccessStructures of New World mammarenavirus glycoproteins as targets for antibody-mediated neutralization
New World mammarenaviruses (NWMs) are viral pathogens endemic to the Americas, where several have acquired the capability for zoonotic transmission, leading to sporadic but potentially lethal viral hemorrhagic fever in humans. Several NWMs are classified as category A pathogens and are considered a persistent threat to human health due to their high case mortality rates, ability to spread through airborne transmission, and limited therapeutic and treatment options against them. Infection is mediated by the tripartite glycoprotein complex (GPC), which is the sole protein expressed on the viral envelope. The GPC, consisting of a receptor-binding domain (GP1), a fusion-enabling domain (GP2), and a stable signal peptide (SSP), governs viral entry initiated through the transferrin receptor 1 (TfR1). Subtle changes in GPC sequence and structure can drastically influence host range, immune recognition, and viral fitness, underscoring its central role in arenavirus pathogenicity and making it a prime target for therapeutic intervention. Over the past decade, advances in structural biology have enabled the elucidation of the molecular architecture of the NWM GPC and its interaction with host receptors and neutralizing antibodies. In this review, we discuss the information gleaned from structural interrogation of the NWM GPC and the significance of these findings on current therapeutic development against these lethal pathogens.
- Open Access
Computationally hybridized pathogenic mammarenavirus receptor binding domains reveal cryptic variants that elicit cross-neutralizing immune responses
The pathogenic mammarenaviruses, Machupo (MACV) and Junin (JUNV), are under evolutionary pressure to leverage human transferrin receptor 1 (hTfR1) for cellular entry while evading host immune responses during zoonosis. We now structurally and functionally investigate cryptic, computationally hybridized JUNV-MACV GP1 sequence variants. We then evaluate the ability of those variants to facilitate internalization of pseudotyped virus-like particles (PVs) into human cells and their recognition by neutralizing antibodies, including plasma from JUNV convalescent patients. We further compare the cryoEM structures of hTfR1-bound MACV GP1 to those of two functional hTfR1-bound MACV-JUNV hybrid GP1 variants that enable robust PV internalization and are also recognized by cross-neutralizing antibodies. Immunization with these variants demonstrates they and other hybrid GP1 sequences can elicit cross-reactive, neutralizing antibodies, supporting a model in which sequence adaptation within GP1 balances receptor recognition with immune evasion. This may inform the rational design of broadly neutralizing GP1-targeted antiviral therapies.
Open AccessComputationally hybridized pathogenic mammarenavirus receptor binding domains reveal cryptic variants that elicit cross-neutralizing immune responses
The pathogenic mammarenaviruses, Machupo (MACV) and Junin (JUNV), are under evolutionary pressure to leverage human transferrin receptor 1 (hTfR1) for cellular entry while evading host immune responses during zoonosis. We now structurally and functionally investigate cryptic, computationally hybridized JUNV-MACV GP1 sequence variants. We then evaluate the ability of those variants to facilitate internalization of pseudotyped virus-like particles (PVs) into human cells and their recognition by neutralizing antibodies, including plasma from JUNV convalescent patients. We further compare the cryoEM structures of hTfR1-bound MACV GP1 to those of two functional hTfR1-bound MACV-JUNV hybrid GP1 variants that enable robust PV internalization and are also recognized by cross-neutralizing antibodies. Immunization with these variants demonstrates they and other hybrid GP1 sequences can elicit cross-reactive, neutralizing antibodies, supporting a model in which sequence adaptation within GP1 balances receptor recognition with immune evasion. This may inform the rational design of broadly neutralizing GP1-targeted antiviral therapies.
- Open Access
- 19 March 2025
- Published by EMBL-EBI
In situ insights into antibody-neutralization of a pre-fusion Junin virus glycoprotein complex
EMPIAR, the Electron Microscopy Public Image Archive centered at EMBL-EBI, is a public resource for raw electron microscopy images related to EMDB, contains micrographs, particle sets and tilt-series.
- 19 March 2025
- Published by EMBL-EBI
Open AccessIn situ insights into antibody-neutralization of a pre-fusion Junin virus glycoprotein complex
EMPIAR, the Electron Microscopy Public Image Archive centered at EMBL-EBI, is a public resource for raw electron microscopy images related to EMDB, contains micrographs, particle sets and tilt-series.
- Open Access
- 19 March 2025
- Published by EMBL-EBI
In situ insights into antibody-neutralization of a pre-fusion Junin virus glycoprotein complex
EMPIAR, the Electron Microscopy Public Image Archive centered at EMBL-EBI, is a public resource for raw electron microscopy images related to EMDB, contains micrographs, particle sets and tilt-series.
- 19 March 2025
- Published by EMBL-EBI
Open AccessIn situ insights into antibody-neutralization of a pre-fusion Junin virus glycoprotein complex
EMPIAR, the Electron Microscopy Public Image Archive centered at EMBL-EBI, is a public resource for raw electron microscopy images related to EMDB, contains micrographs, particle sets and tilt-series.